Ads
related to: carcinoid tumor
Search results
Stages of Lung Cancer Listed by Type
Verywell Health via Yahoo News· 6 months agoWith an Explanation of Symptom ProgressionMedically reviewed by Reza Samad, MD The stages of lung cancer range from 0 to 4 based on how advanced the...
Amryt (AMYT) Mycapssa Gets Orphan Drug Tag for Carcinoid Syndrome
Zacks via Yahoo Finance· 2 years agoAmryt Pharma plc AMYT announced that the FDA has granted Orphan Drug designation to its marketed...
Crinetics Pharmaceuticals Inc (CRNX) Reports Q1 2024 Financial Results
GuruFocus.com via Yahoo Finance· 2 weeks agoRevenue: Reported $0.6 million for Q1 2024, exceeding the estimated $0.26 million. Net Loss:...
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2023 Earnings Call Transcript February 29, 2024...
Actor Adan Canto, 42, dies following battle with rare cancer: What is appendiceal cancer?
Yahoo Canada Style· 4 months agoActor Adan Canto, 42, died after developing cancer of the appendix. (Photo by Jason...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 months agoNEWSPLUS The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1102 ET...
Actor Adan Canto died of appendiceal cancer at age 42. Here's what to know about the disease.
Yahoo Life Style via AOL· 4 months agoAdan Canto died from appendiceal cancer at age 42. (Getty Images) Jim Spellman via Getty Images On...
Crinetics Pharmaceuticals Inc (CRNX) Reports Increased R&D Investment Amidst Net Loss ...
GuruFocus.com via Yahoo Finance· 3 months agoResearch and Development Expenses: Increased to $168.5 million in 2023 from $130.2 million in 2022. General and Administrative Expenses: Rose to $58.1 million in 2023 from $42.4 million in 2022 ...
Crinetics (CRNX) Stock Surges 70% in a Month: Here's Why
Zacks via Yahoo Finance· 8 months agoCrinetics (CRNX) surges 69.6% in a month due to encouraging results from its late-stage study,...
Endocrine Disease-Focused Crinetics Pharmaceuticals Stock Soars On Tuesday - Here's Why
Benzinga via Yahoo Finance· 2 months agoTuesday, Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) released topline results from PATHFNDR-2, the...